Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company PR Newswire MADISON, Wisconsin, Nov. 8, 2019 Combined company joins two leading brands...
Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company PR Newswire MADISON, Wis., Nov. 8, 2019 Combined company joins two leading brands in...
Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences PR Newswire REDWOOD CITY, Calif., Nov. 7, 2019 REDWOOD CITY, Calif., Nov. 7, 2019 /PRNewswire/ -- Genomic Health...
Shenandoah Telecommunications Set to Join S&P SmallCap 600 PR Newswire NEW YORK, Nov. 4, 2019 NEW YORK, Nov. 4, 2019 /PRNewswire/ -- Shenandoah Telecommunications Co. (NASD: SHEN) will...
Moore Kuehn, PLLC Encourages Genomic Health, Inc. and Carbonite, Inc. Investors to Contact Firm PR Newswire NEW YORK, Oct. 17, 2019 NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a...
New TAILORx Data, Published Today in JAMA Oncology, Add to Strong Evidence Base Reinforcing Unique Ability of Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy Treatment PR...
New St. Gallen International Breast Cancer Guidelines Recommend Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy for Node-negative and Node-positive Early-stage Breast Cancer...
New St. Gallen International Breast Cancer Guidelines Recommend Oncotype DX Breast Recurrence Score® Test to Guide Chemotherapy for Node-negative and Node-positive Early-stage Breast Cancer PR...
SHAREHOLDER ALERT: WeissLaw LLP Investigates Genomic Health, Inc. PR Newswire NEW YORK, July 29, 2019 NEW YORK, July 29, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of...
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Genomic Health, Inc. has obtained a Fair Price in its sale to Exact Sciences Corp. PR Newswire MILWAUKEE, July 29, 2019...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
